Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer - A prospective double-blinded study at two hospital centers;Diagnostischer stellenwert der ganzkörper-MRT und der skelettszintigrafie in der ossären metastasendetektion bei mammakarzinompatientinnen - Eine prospektive doppelblindstudie an zwei klinikzentren

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 181, Issue 3, 2009, Pages 255-263

  Ohlmann Knafo, Susanne ^a   Kirschbaum, M ^a   Fenzl, G ^b   Pickuth, D ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Department of Orthopaedic Surgery   (Germany)

Author keywords

Bone metastases; Bone scintigraphy; Breast cancer; Whole body MRI

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; WHOLE BODY MRI; BONE; BONE TUMOR; BREAST TUMOR; COMPARATIVE STUDY; IMAGE PROCESSING; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; SPINAL CORD TUMOR; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; SPINAL NEOPLASMS; TECHNETIUM TC 99M MEDRONATE; WHOLE BODY IMAGING;

DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM TC 99M HYDROXYMETHYLENE DIPHOSPHONATE;

EID: 61549140377     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0028-1109104     Document Type: Article

References (21)

1. Altehoefer C, Ghanem N, Högerle S et al. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol 2001; 40: 16-23 (Pubitemid 32982905)
2. Ghanem N, Altehoefer C, Högerle S et al. Ganzkörper-MRT vs. Skelettszintigraphie bei der Detektion ossärer Metastasen solider Tumoren. Radiologe 2004; 44: 864-874
3. Steinborn M, Wörtler K, Nathrath M et al. Ganzkörper-MRT bei Langerhans-Zell-Histiozytose im Kindes- und Jugendalter zur Beurteilung des Skelettsystems. Fortschr Röntgenstr 2008; 180: 646-653
4. Eustace S, Tello R, DeCarvalho V et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. Am J Roentgenol 1997; 169: 1655-1661 (Pubitemid 127469800)
5. Steinborn M, Tiling R, Heuck A et al. Diagnostik der Metastasierung im Knochenmark mittels MRT. Radiologe 2000; 40: 826-834 (Pubitemid 30743274)
6. Lauenstein TC, Freudenberg LS, Goehde SC et al.Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002; 12: 2091-2099
7. Ladd SC, Zenge M, Antoch G et al. MR-Ganzkörperdiagnostik. Fortschr Röntgenstr 2006; 178: 763-770
8. Nakanishi K, Kobayashi M, Takahashi S et al. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams. Magn Reson Med Sci 2005; 4: 11-17
9. Lecouvet FE, Geukens D, Stainier A et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 2007; 25: 3281-3287 (Pubitemid 47325613)
10. Toshiaki T, Mayr NA, Lee HJ et al. Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy. Am J Roentgenol 2001; 176: 1525-1530 (Pubitemid 32510275)
11. Ketelsen D, Röthke M, Aschoff P et al. Nachweis ossärer Metastasen des Prostatakarzinoms - Vergleich der Leistungsfähigkeit der Ganzkörper-MRT und der Skelettszintigrafie. Fortschr Röntgenstr 2008; 180: 746-752
12. Tausig A, Manthey N, Berger F et al. Vorzüge und Limitationen der Ganzkörper-Knochenmark-MRT mit Turbo-STIR-Sequenzen im Vergleich zur planaren Skelettszintigrafie. Nuklearmedizin 2000; 39: 174-179 (Pubitemid 30786406)
13. Traill ZC, Talbot D, Golding S et al. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases. Clin Radiol 1999; 54: 448-451 (Pubitemid 29355976)
14. Rieden K. Knochenmetastasen. Radiologische Diagnostik, Therapie und Nachsorge. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong: Springer-Verlag, 1988; 1: 1-2
15. Thurairaja R, McFarlane J, Traill Z et al. State-of-the-art approches to detecting early bone metastasis in prostate cancer. BJU Int 2004; 94: 268-271 (Pubitemid 39120162)
16. Schmidt GP, Baur-Melnyk A, Tiling R et al. Hochauflösendes Ganzkörper-Tumor-Staging unter Verwendung paralleler Bildgebung im Vergleich zur PET-CT: erste Erfahrungen auf einem 32-Kanal-MRT-System. Radiologe 2004; 44: 889-898 (Pubitemid 39362022)
17. Schmidt GP, Schoenberg SO, Schmid R et al. Screening for bone metastases: whole-body MRI using a 32-channel systemversus dual-modality PET-CT. Eur Radiol 2007; 17: 939-949 (Pubitemid 46766875)
18. Ghanem N, Uhl M, Brink I et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005; 55: 41-55 (Pubitemid 40798487)
19. Kreienberg R, Kopp I, Albert U et al. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. In: Deutsche Krebsgesellschaft e.V., Informationszentrum für Standards in der Onkologie (ISTO) (Hrsg). Berlin, 2008; 112: 24-25
20. Alderson PO, Adams DF, McNeil BJ et al. Computed tomography, ultrasound, and scintigraphy of the liver with colon or breast carcinoma: a prospective comparison. Radiology 1983; 149: 225-230
21. Crump M, Goss PE, Prince M et al. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes. J Clin Oncol 1996; 14: 66-69 (Pubitemid 26019998)